Buyer questions · Purchase decisions
In addition to FDA filing, what clinical or animal-substitute safety evidence is required to launch new products containing active ingredients like retinol or niacinamide in Thailand?
Launching new products in Thailand requires a Pre-market notification filed with Thai FDA, with a Thai-registered importer or manufacturer as the statutory responsible party. Current regulations do not mandate clinical or animal-substitute safety evidence unless the active ingredients (like retinol or niacinamide) trigger prohibited/restricted lists or claims involve medical benefits. Formulations must be pre-screened against ASEAN directives (ACD) annexes for prohibited and restricted substances, pending the latest official text. Packaging copy must strictly avoid risk words implying "anti-wrinkle/whitening" that could trigger medical review. Basic physico-chemical, microbiological, and stability test reports are recommended to support the safety assessment.
1Filing Entity & Channel
The notifier must be a Thai-registered importer or manufacturer. A Pre-market notification is filed electronically with Thai FDA; the receipt is valid for 3 years. Thai labels must include INCI list, batch number, and warnings (applied within 30 days of import). (Subject to latest official text)
2Safety Evidence Requirements
Routine notifications do not strictly require clinical reports or in-vitro toxicology tests. Formulations must pass physico-chemical, microbiological, and ISO 11930 preservative challenge tests. If claims involve whitening/anti-wrinkle, a safety assessment report proving non-medical attributes may be requested. Retain complete exposure and safety files for inspection.
3Active Ingredient Compliance Check
Retinol and Niacinamide must be checked against ASEAN directives (ACD) for restricted concentrations and prohibited status. Monitor the 2026 draft updates on prohibited/restricted substances (e.g., BHT, Benzophenone); substitutions are required if the formulation contains the listed ingredients.
Follow-up questions
- Q:How long does the filing process usually take?
- A:Routine notifications have no fixed statutory review period, but Thai FDA administrative processing times vary by case. Submit early and track progress, allowing time for label application and compliance confirmation.
- Q:Can Thailand filing be used in other ASEAN countries?
- A:No. Each ASEAN member state has independent regulatory bodies. A Thailand filing has no legal status in other countries; applications must be resubmitted individually for each jurisdiction.
Figures sourced from:各国法规 · 泰国泰国护肤代工东盟化妆品指令附录配方库
Updated 2026-09-18
Want this worked out for your category and target market? Send an inquiry